VPS13C
Basic information
Region (hg38): 15:61852389-62060473
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
- autosomal recessive early-onset Parkinson disease 23 (Moderate), mode of inheritance: AR
- young-onset Parkinson disease (Supportive), mode of inheritance: AR
- autosomal recessive early-onset Parkinson disease 23 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Parkinson disease 23, autosomal recessive, early onset | AR | Neurologic | Individuals have been described with levodopa response | Neurologic | 26942284 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (11 variants)
- Autosomal recessive early-onset Parkinson disease 23 (6 variants)
- Parkinson disease (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VPS13C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 147 | 29 | 179 | |||
missense | 298 | 33 | 26 | 358 | ||
nonsense | 13 | 11 | 32 | |||
start loss | 0 | |||||
frameshift | 20 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 17 | |||||
splice region | 10 | 34 | 7 | 51 | ||
non coding | 91 | 155 | 252 | |||
Total | 18 | 27 | 331 | 272 | 210 |
Highest pathogenic variant AF is 0.0000132
Variants in VPS13C
This is a list of pathogenic ClinVar variants found in the VPS13C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-61854399-C-T | Benign (May 20, 2021) | |||
15-61854469-T-C | Benign (Mar 22, 2023) | |||
15-61854478-G-C | Likely benign (Nov 22, 2023) | |||
15-61854490-T-G | Likely benign (Jan 19, 2024) | |||
15-61854507-A-G | Likely benign (Apr 30, 2022) | |||
15-61854523-C-T | Likely benign (Apr 24, 2023) | |||
15-61854543-T-C | Benign/Likely benign (Aug 01, 2024) | |||
15-61854545-G-T | Uncertain significance (Nov 17, 2021) | |||
15-61854770-T-A | Benign (May 16, 2021) | |||
15-61854857-T-G | Likely benign (Jun 12, 2022) | |||
15-61854884-G-T | Uncertain significance (Nov 17, 2022) | |||
15-61854888-C-A | Conflicting classifications of pathogenicity (Feb 22, 2023) | |||
15-61854904-T-G | Likely benign (Nov 13, 2021) | |||
15-61854917-T-C | Uncertain significance (May 09, 2022) | |||
15-61854919-A-T | Inborn genetic diseases | Uncertain significance (Aug 12, 2021) | ||
15-61854947-C-T | Likely benign (Jan 19, 2024) | |||
15-61854971-A-G | Benign (Dec 22, 2023) | |||
15-61855008-T-A | Benign (May 16, 2021) | |||
15-61856283-T-C | Uncertain significance (Mar 25, 2022) | |||
15-61856297-T-C | Uncertain significance (Aug 05, 2021) | |||
15-61856305-A-G | Uncertain significance (Nov 23, 2021) | |||
15-61856316-G-A | Likely benign (Aug 03, 2021) | |||
15-61856331-T-C | Likely benign (May 22, 2022) | |||
15-61856365-C-T | Uncertain significance (Dec 21, 2021) | |||
15-61856381-T-G | Likely benign (Jul 19, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VPS13C | protein_coding | protein_coding | ENST00000261517 | 85 | 208085 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.65e-49 | 1.00 | 124995 | 0 | 753 | 125748 | 0.00300 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.29 | 1994 | 1.84e+3 | 1.08 | 0.0000903 | 24642 |
Missense in Polyphen | 575 | 583.44 | 0.98553 | 7973 | ||
Synonymous | -2.53 | 722 | 640 | 1.13 | 0.0000316 | 6963 |
Loss of Function | 5.40 | 110 | 190 | 0.578 | 0.00000964 | 2546 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00369 | 0.00362 |
Ashkenazi Jewish | 0.00110 | 0.00109 |
East Asian | 0.000744 | 0.000707 |
Finnish | 0.0110 | 0.0108 |
European (Non-Finnish) | 0.00319 | 0.00307 |
Middle Eastern | 0.000744 | 0.000707 |
South Asian | 0.00167 | 0.00154 |
Other | 0.00268 | 0.00245 |
dbNSFP
Source:
- Function
- FUNCTION: Necessary for proper mitochondrial function and maintenance of mitochondrial transmembrane potential. Involved in the regulation of PINK1/PRKN-mediated mitophagy in response to mitochondrial depolarization. {ECO:0000269|PubMed:26942284}.;
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.971
- rvis_EVS
- -0.81
- rvis_percentile_EVS
- 12.08
Haploinsufficiency Scores
- pHI
- 0.211
- hipred
- N
- hipred_score
- 0.466
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.449
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Vps13c
- Phenotype
- hematopoietic system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- protein targeting to vacuole;Golgi to endosome transport;mitochondrion organization;protein retention in Golgi apparatus;negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization
- Cellular component
- cytoplasm;mitochondrial outer membrane;cytosol;extrinsic component of membrane;extracellular exosome
- Molecular function